• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Search Results

 Magnesium Sulfate Injection

 Status: Currently in Shortage

 » Date first posted: No date available
 » Therapeutic Categories: Gastroenterology; Neurology; Pediatric; Total Parenteral Nutrition

American Regent/Luitpold (Reverified 12/11/2014)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/mL, 2 mL vial (NDC 00517-2602-25) Unavailable - No product available for release. No plan to manufacture. American Regent is currently not releasing Magnesium Sulfate Injection. Other
500 mg/mL, 10 mL vial (NDC 00517-2610-25) Unavailable - No product available for release. No plan to manufacture. American Regent is currently not releasing Magnesium Sulfate Injection. Other
500 mg/mL, 50 mL vial (NDC 00517-2650-25) Unavailable - No product available for release. No plan to manufacture. American Regent is currently not releasing Magnesium Sulfate Injection. Other

Fresenius Kabi USA, LLC (Reverified 12/17/2014)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/mL, 2 mL vial (NDC 63323-0064-02) Backordered. Next release anticipated Q-1 2015. Demand increase for the drug
500 mg/mL, 10 mL vial (NDC 63323-0064-10) Backordered. Next release anticipated January 2015. Demand increase for the drug
500 mg/mL, 20 mL vial (NDC 63323-0064-20) Backordered. Next release anticipated December 2014. Demand increase for the drug
500 mg/mL, 50 mL vial (NDC 63323-0064-50) Backordered. Next release anticipated December 2014. Check wholesaler inventory Demand increase for the drug

Hospira, Inc. (Revised 12/18/2014)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50%; 10 mL Ansyr syringe (NDC 0409-1754-10) Next delivery February 2015. Estimated recovery 1Q 2015. Please check with your wholesaler for available inventory. Shortages per Manufacturer: Manufacturing delay. Other
40 mg/mL in Water for Inj; 50 mL bag (NDC 0409-6729-24) Available Please check with your wholesaler for available inventory. Shortages per Manufacturer: Available. Other
40 mg/mL in Water for Inj; 100 mL bag (NDC 0409-6729-23) Next delivery: December 2014; Estimated recovery 4Q 2014 Please check with your wholesaler for available inventory. Shortages per Manufacturer: Manufacturing Delay. Other
40 mg/mL in Water for Inj; 500 mL bag (NDC 0409-6729-03) Next delivery: February 2015; Estimated recovery: 1Q 2015 Please check with your wholesaler for available inventory. Shortages per Manufacturer: Manufacturing Delay. Other
40 mg/mL in Water for Inj; 1000 mL bag (NDC 0409-6729-09) Available Please check with your wholesaler for available inventory. Shortages per Manufacturer: Available. Other
10 mg/mL in 5% Dextrose Inj; 100 mL bag (NDC 0409-6727-23) Available Please check with your wholesaler for available inventory. Shortages per Manufacturer: Available. Other
80 mg/mL in Water for Inj; 50 mL bag (NDC 0409-6730-13) Available Please check with your wholesaler for available inventory. Shortages per Manufacturer: Available. Other
50%; 20 mL vial (NDC 0409-2168-02) Next delivery: January 2015; Estimated recovery 1Q 2015 Please check with your wholesaler for available inventory. Shortages per Manufacturer: Manufacturing Delay. Other
-
-